Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eileen Francis

Eileen Francis is a reporter for “The Tan Sheet,” where she follows news on OTC drug and nutritional product manufacturing, regulation, legislation, finance and research. She previously served as a reporter and editor of “The Rose Sheet,” IBI’s source for in-depth coverage of the cosmetics industry. Early in her career, Eileen worked in public relations and as a writer for a lobbying firm. Outside of IBI, her freelance work includes articles on business, art and travel.
Set Alert for Articles By Eileen Francis

Latest From Eileen Francis

Opioid-Withdrawal 'Aids' Warrant Immediate FDA, FTC Action – CSPI

FDA and the Federal Trade Commission should bring immediate enforcement action against marketers of non-kratom dietary supplements promoted as opioid-withdrawal aids, says the Center for Science in the Public Interest in letters to the agency and commission Dec. 8. The nonprofit identified eight supplement products making opioid-withdrawal claims without sufficient science to support the statements.

FDA Regulation

FDA Says No To Street Drug Alternatives Posing As Supplements

The agency warns Arco Globus Trading LLC to immediately stop marketing purported dietary supplements that it promotes as alternatives to illicit street drugs, including one with an active pharmaceutical antihistamine. The firm's Legal Lean Syrup and Coco Loko are unapproved and misbranded new drugs, the agency says.

FDA Regulation

Nonprofit Pharma Targets Making Naloxone Available OTC, Trimming Price

Nonprofit Harm Reduction Therapeutics targets an OTC switch of naloxone, an opioid antagonist used to reverse an opioid overdose. It aims to make the product available at low cost in 110,000 retail locations nationwide.

Consumer Prescription To Otc Switch

NPA Submits Wish List For Reducing FDA Regulatory Burdens Per Trump Order

FDA’s NDI notification draft guidance should be rewritten and its Nutrition Facts and Supplement Facts Final Rule delayed, the Natural Products Association says in comments submitted to the agency in response to President Trump’s executive order aimed at cutting down on burdensome regulations.

Consumer Dietary Supplements

Unusual Supplement Adverse Events Could Be 'Canary' Of Problem

Post-market surveillance system for dietary supplements should contain a process for identifying sentinel events, or low-incidence and unusual adverse events that can indicate big problems, says a toxicologist speaking during a recent Council for Responsible Nutrition webinar.

Dietary Supplements Consumer

SARMs Supplement Researchers Call For Online Sales Crackdown

A JAMA study finds SARMs in 23 of 44 products marketed online as containing the steroid-like ingredient while the rest contained other unapproved drugs and substances. Sports medicine and doping researchers say e-commerce provides cover for firms to sell the risky bodybuilding drugs without consequence.

Dietary Supplements Consumer
See All